title: Potential of radiosensitizing agents in cancer chemo-radiotherapy.
abstract: Potential of herbs and other plant-based formulations have been increasingly recognized in prevention and treatment of human diseases including cancer. There exist enormous prospect for screening and evaluation of herbal/plant products for developing effective radiosensitization and radioprotection relevant to nuclear research program. Investigations in our laboratory have focused on the mechanism of activity of variety of anticancer and antioxidant agents, namely, Eugenol, (EU), Ellagic acid (EA), Triphala (TPL), Tocopherol Succinate (TOS) and Arachidonic acid on normal and cancer cells with view to design effective protocols in practical radioprotection and cancer radiotherapy. This paper is mainly focused on studies on cytotoxic effects on cancer cell lines. Results have shown that these agents produced radiosensitizing action involving oxidative damage, membrane alteration and damage to nucleic acid in various human cell lines. Studies were performed employing fluorescence probes and electron spin resonance methods and gel electrophoresis protocols. It has been found that cytotoxic effect was induced by initiating membrane oxidative damage and by triggering intracellular generation of reactive oxygen species (ROS) by gamma radiation in combination with phytochemicals like TPL, EA and TOS in tumor cell line Ehrlich Ascites (EAC), Human cervical (HeLa) and breast (MCF-7) cells. Membrane damage and ROS generation was measured by DPH and DCF-FDA fluorescent probes respectively after exposure to low to moderate doses of gamma radiation. This talk will present the cytotoxic effects of phytochemicals in combination with ionizing radiation. It is emphasized that modulation of membrane peroxidative damage and intra cellular ROS may help achieve efficient killing of cancer cells which may provide a new approach to developing effective treatment of cancer.
authors.affiliation: Radiation Biology and Health Sciences Division Bhabha Atomic Research Centre, Mumbai 400 085, India.
authors.forename: S
authors.initials: S
authors.lastname: Girdhani
authors.forename: S M
authors.initials: SM
authors.lastname: Bhosle
authors.forename: S A
authors.initials: SA
authors.lastname: Thulsidas
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: K P
authors.initials: KP
authors.lastname: Mishra
mesh_terms: D017209:Apoptosis; D016718:Arachidonic Acid / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004610:Ellagic Acid / Q000627:therapeutic use; D005054:Eugenol / Q000627:therapeutic use; D006801:Humans; D015227:Lipid Peroxidation; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D010936:Plant Extracts / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D017382:Reactive Oxygen Species / Q000378:metabolism; D024505:Tocopherols; D014810:Vitamin E / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010936:Plant Extracts; D011838:Radiation-Sensitizing Agents; D017382:Reactive Oxygen Species; C520904:triphala; D014810:Vitamin E; D004610:Ellagic Acid; D016718:Arachidonic Acid; D005054:Eugenol; D024505:Tocopherols